Psoriasis Clinical Trial – NOW ENROLLING

Do you know anyone suffering from psoriasis? Call Today – 855.554.6374

note: Qualified study participants will receive study drug, related testing, and compensation for their time and travel.

Clinical Trial Government Identifier #NCT03624127

Sponsor: Bristol-Myers Squibb


Genders eligible for study: Male/Female Ages eligible for study: 18 and older
NEW STUDY NOW ENROLLING  – Moderate to Severe plaque psoriasis present for at least 6 months; no prior use of apremilast allowed July 2018 – July 2020

Don’t qualify? Check out our other clinical trials for psoriasis.